BioCentury
ARTICLE | Financial News

Myovant raises $75M

July 20, 2018 5:47 PM UTC

Myovant Sciences Ltd. (NYSE:MYOV) raised $75 million through the sale of 3.3 million shares at $22.50 in a follow-on underwritten by J.P. Morgan, Goldman Sachs, Barclays, JMP Securities and Baird. The price is a 7% discount to its close of $24.10 on July 11, when it proposed the follow-on after trading hours. Myovant shed 4% on July 12, and then slipped another $2.05 to $21 on July 13. ...